1.Shlaes, D, Levy, S, Archer, G. Antimicrobial resistance: new directions. American Society of Microbiology News 1991;57:455–458.
2.Shlaes, DM, Gerding, DN, John, JF Jr, Craig, WA, Bornstein, DL, Duncan, RA, et al. Society of Healthcare Epidemiology of America and Infectious Disease Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infect Control Hosp Epidemiol 1997;18:275–291.
3.Dominguez, EA, Davis, JC, Langnas, AN, Wmfield, B, Cavalieri, SJ, Rupp, ME. An outbreak of vancomycin-resistant Enterococcus faecium in liver transplant recipients. Liver Transpl Surg 1997;3:586–590.
4.Cavalieri, SJ, Hotstetter, MK, Rupp, ME, Dominguez, EA. Synergy studies on and therapy for multiply antibiotic resistant Enterococcus faecium from a recent outbreak Presented at the 32nd Annual Meeting of the Infectious Diseases Society of America; Orlando, Florida; October 8, 1994. Abstract 179.
5.McGowan, JE Jr. Minimizing antimicrobial resistance in hospital bacteria: can switching or cycling drugs help? Infect Control 1986;7:573–576.
6.Gerding, DN, Larson, TA, Hughes, RA, Wiler, M, Shanholtzer, C, Peterson, LR. Aminoglycoside resistance and aminoglycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 1991;35:1284–1290.
7.King, JW, White, MC, Todd, JR, Conrad, SAAlterations in the microbial flora and in the incidence of bacteremia at a university hospital after adoption of amikacin as the sole formulary aminoglycoside. Clin Infect Dis 1992;14:908–915.
8.Kollef, MH, Vlasnik, J, Sharpless, L, Pasque, C, Murphy, D, Fraser, V. Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 1997;156:1040–1048.
9.Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.
10.Sanders, WE, Sanders, CC. Cycling of antibiotics: an approach to circumvent resistance in specialized units of the hospital. Clin Microbiol Infect 1996;1:223–225.
11.Hughes, WT, Armstrong, D, Bodey, GP, Feld, R, Mandeli, GL, Meyers, JD, et al. From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990;161:381–396.
12.Rahmpal, R. Is monotherapy for febrile neutropenia still a viable alternative? Clin Infect Dis 1999;29:508–514.
13.Engels, EA, Ellis, CA, Supran, SE, Schmid, CH, Barza, M, Schenken, DP, et al. Early infection in bone marrow transplantation: quantitative study of clinical factors that affect risk. Clin Infect Dis 1999;28:256–266.
14.Heizmann, WR. Circumventing antibiotic resistance in specialized hospital units. Clin Microbiol Infect 1997;3:133–134.
15.Schentag, JJ. The results of a targeted pharmacy intervention program. Clin Ther 1993;15(suppl A):29–36.
16.John, JF Jr, Rice, LB. The microbial genetics of antibiotic cycling. Infect Control Hosp Epidemiol 2000;21(suppl):S22–S31.
17.McGowan, JE Jr, Tenover, FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997;11:297–311.